Borisov Se, Edvardas Danila, Andrei Maryandyshev, Margareth Pretti Dalcolmo et al.
The World Health Organization (WHO) recommends that countries implement pharmacovigilance and collect information on active drug safety monitoring (aDSM) and management of adverse events. The aim of this prospective study was to evaluate the frequency and severity of adverse events to anti-tuberculo...
Onno W. Akkerman, Alena Aleksa, Jan‐Willem C. Alffenaar, Nada Hassan Al-Marzouqi et al.
The World Health Organization launched a global initiative, known as aDSM (active TB drug safety monitoring and management) to better describe the safety profile of new treatment regimens for drug-resistant tuberculosis (TB) in real-world settings. However, comprehensive surveillance is difficult to...
S Koirala, Borisov Se, Edvardas Danila, Andrei Mariandyshev et al.
The World Health Organization (WHO) recommends countries introduce new anti-TB drugs in the treatment of multidrug-resistant tuberculosis. The aim of the study is to prospectively evaluate the effectiveness of bedaquiline (and/or delamanid)- containing regimens in a large cohort of consecutive TB pa...
Andreas Bruder, Isabel Rodrigues Fernandes, Red Calore, Pietro Marchese et al.
The biodiversity of aquatic fungi remains vastly underexplored, including the taxonomy and biogeography of species and their responses to environmental changes. Aquatic fungi contribute substantially to ecosystem processes and services, and interact with other organisms in aquatic food webs, as deco...